Day Zero Diagnostics, Inc. – Trademark Portfolio
Entity Type: 03
Day Zero Diagnostics, Inc. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include EPIXACT, EPIXOME, KEYNOME, MICROHMDB, and DAY ZERO DIAGNOSTICS. The owner is based in Watertown, MA.
250 Arsenal Street, Suite 320
Watertown, MA 02472
Showing of trademarks Trademarks
Trademark Classifications
Day Zero Diagnostics, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Day Zero Diagnostics, Inc. have?
Day Zero Diagnostics, Inc. has 7 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 abandoned.
What trademark classes does Day Zero Diagnostics, Inc. file in?
Day Zero Diagnostics, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Day Zero Diagnostics, Inc.'s most well-known trademarks?
Day Zero Diagnostics, Inc.'s registered trademark portfolio includes well-known marks such as EPIXACT, EPIXOME, KEYNOME, MICROHMDB, and DAY ZERO DIAGNOSTICS. These are among 5 currently registered trademarks in the portfolio.
What is Day Zero Diagnostics, Inc.'s trademark registration success rate?
Day Zero Diagnostics, Inc. has a 71% trademark registration rate, with 5 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.